All data are based on the daily closing price as of November 13, 2026
s

Seegene

096530.KQ
18.45 USD
-0.39
-2.07%

Overview

Last close
18.45 usd
Market cap
840.46M usd
52 week high
29.06 usd
52 week low
14.31 usd
Target price
35.21 usd

Valuation

P/E
12.466
Forward P/E
70.4225
Price/Sales
2.2055
Price/Book Value
1.081
Enterprise Value
502.55M usd
EV/Revenue
1.3174
EV/EBITDA
3.7532

Key financials

Revenue TTM
381.48M usd
Gross Profit TTM
252.71M usd
EBITDA TTM
96.65M usd
Earnings per Share
1.51 usd
Dividend
0.97 usd
Total assets
818.13M usd
Net debt
N/A usd

About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
  • Symbol
    096530.KQ
  • Exchange
    KQ
  • Isin
    KR7096530001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Dr. Jong-Yoon Chun
  • Headquarter
    Seoul
  • Web site
    https://www.seegene.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top